133 related articles for article (PubMed ID: 8837143)
1. Neuroblastoma-associated paraneoplastic syndrome with anti-Hu antineuronal antibodies presenting at the time of recurrence.
Mpofu C; Sztriha L; Revesz T
Pediatr Hematol Oncol; 1996; 13(4):369-73. PubMed ID: 8837143
[TBL] [Abstract][Full Text] [Related]
2. Opsoclonus-myoclonus and antineuronal antibodies in neuroblastoma.
Blatt J
Pediatr Hematol Oncol; 1996; 13(5):iii-v. PubMed ID: 10897807
[No Abstract] [Full Text] [Related]
3. Anti-Hu antibody in a neuroblastoma-associated paraneoplastic syndrome.
Fisher PG; Wechsler DS; Singer HS
Pediatr Neurol; 1994 Jun; 10(4):309-12. PubMed ID: 8068157
[TBL] [Abstract][Full Text] [Related]
4. Paraneoplastic antineuronal antibodies in patients with systemic autoimmune diseases.
Benyahia B; Amoura Z; Rousseau A; Le Clanche C; Carpentier A; Piette JC; Delattre JY
J Neurooncol; 2003 May; 62(3):349-51. PubMed ID: 12777089
[TBL] [Abstract][Full Text] [Related]
5. Paraneoplastic opsoclonus-myoclonus associated with anti-Hu antibody.
Hersh B; Dalmau J; Dangond F; Gultekin S; Geller E; Wen PY
Neurology; 1994 Sep; 44(9):1754-5. PubMed ID: 7936310
[TBL] [Abstract][Full Text] [Related]
6. Anti-hu paraneoplastic syndrome presenting as bilateral sixth cranial nerve palsies.
Hammam T; McFadzean RM; Ironside JW
J Neuroophthalmol; 2005 Jun; 25(2):101-4. PubMed ID: 15937431
[TBL] [Abstract][Full Text] [Related]
7. Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies.
Uchuya M; Graus F; Vega F; Reñé R; Delattre JY
J Neurol Neurosurg Psychiatry; 1996 Apr; 60(4):388-92. PubMed ID: 8774401
[TBL] [Abstract][Full Text] [Related]
8. Major histocompatibility proteins, anti-Hu antibodies, and paraneoplastic encephalomyelitis in neuroblastoma and small cell lung cancer.
Dalmau J; Graus F; Cheung NK; Rosenblum MK; Ho A; Cañete A; Delattre JY; Thompson SJ; Posner JB
Cancer; 1995 Jan; 75(1):99-109. PubMed ID: 7804984
[TBL] [Abstract][Full Text] [Related]
9. Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies.
Lucchinetti CF; Kimmel DW; Lennon VA
Neurology; 1998 Mar; 50(3):652-7. PubMed ID: 9521251
[TBL] [Abstract][Full Text] [Related]
10. Antineuronal Nuclear Autoantibody Type 1/Anti-Hu-Associated Opsoclonus Myoclonus and Epilepsia Partialis Continua: Case Report and Literature Review.
Sweeney M; Sweney M; Soldán MM; Clardy SL
Pediatr Neurol; 2016 Dec; 65():86-89. PubMed ID: 27707529
[TBL] [Abstract][Full Text] [Related]
11. Anti-Hu antibodies may indicate a positive response to chemotherapy in paraneoplastic syndrome secondary to small cell lung cancer.
Douglas CA; Ellershaw J
Palliat Med; 2003 Oct; 17(7):638-9. PubMed ID: 14594156
[TBL] [Abstract][Full Text] [Related]
12. Ofatumumab for refractory opsoclonus-myoclonus syndrome following treatment of neuroblastoma.
Ketterl TG; Messinger YH; Niess DR; Gilles E; Engel WK; Perkins JL
Pediatr Blood Cancer; 2013 Dec; 60(12):E163-5. PubMed ID: 23813921
[TBL] [Abstract][Full Text] [Related]
13. [Paraneoplastic opsoclonus-myoclonus syndrome revealing T-cell lymphoma].
Ducrocq X; Petit J; Taillandier L; Dorvaux V; Anxionnat R; Plénat F; Vespignani H
Presse Med; 1999 Feb; 28(7):330-3. PubMed ID: 10083874
[TBL] [Abstract][Full Text] [Related]
14. Intrathecal synthesis of the anti-Hu antibody in patients with paraneoplastic encephalomyelitis or sensory neuronopathy: clinical-immunologic correlation.
Vega F; Graus F; Chen QM; Poisson M; Schuller E; Delattre JY
Neurology; 1994 Nov; 44(11):2145-7. PubMed ID: 7969974
[TBL] [Abstract][Full Text] [Related]
15. Nuclear localization of anti-Hu antibody is not associated with in vitro cytotoxicity.
Hormigo A; Lieberman F
J Neuroimmunol; 1994 Dec; 55(2):205-12. PubMed ID: 7829670
[TBL] [Abstract][Full Text] [Related]
16. Paraneoplastic gastro-intestinal anti-Hu syndrome in neuroblastoma.
Drukker CA; Heij HA; Wijnaendts LC; Verbeke JI; Kaspers GJ
Pediatr Blood Cancer; 2009 Mar; 52(3):396-8. PubMed ID: 18989884
[TBL] [Abstract][Full Text] [Related]
17. Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma.
Horibe K; Fukuda M; Miyajima Y; Matsumoto K; Kondo M; Inaba J; Miyashita Y
Med Pediatr Oncol; 2001 Jan; 36(1):203-4. PubMed ID: 11464885
[TBL] [Abstract][Full Text] [Related]
18. Bilateral tonic pupils with evidence of anti-hu antibodies as a paraneoplastic manifestation of small cell lung cancer.
Wabbels BK; Elflein H; Lorenz B; Kolling G
Ophthalmologica; 2004; 218(2):141-3. PubMed ID: 15004505
[TBL] [Abstract][Full Text] [Related]
19. Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group Study.
Rudnick E; Khakoo Y; Antunes NL; Seeger RC; Brodeur GM; Shimada H; Gerbing RB; Stram DO; Matthay KK
Med Pediatr Oncol; 2001 Jun; 36(6):612-22. PubMed ID: 11344492
[TBL] [Abstract][Full Text] [Related]
20. Anti-Hu autoantibody associated sensory neuropathy/encephalomyelitis: a model of paraneoplastic syndrome.
Posner JB
Perspect Biol Med; 1995; 38(2):167-81. PubMed ID: 7899054
[No Abstract] [Full Text] [Related]
[Next] [New Search]
